Re: [Geuvadis_rna_analysis] RNAseq TC on Feb 14th - main paper in revision

Hello, As background material for discussing the revisions on tomorrow's call, here's a todo list of revisions. For your information, I also included the rebuttal letter that was sent to Nature, but it's quite long and there's no need to go through it in detail. To follow the advice of the editor, we'll need to make the paper more focused, and cut some points that are not essential for the main message of regulatory variation, and we didn't really have space to discuss in adequate length anyway. I'm sad to say that this will mean cutting analyses that many of you worked hard on - RNA editing, subtle splicing, fusion transcripts. I hope that you understand that we just have to do what we're told to do. This will of course not affect authorship in any way, and if you are interested using your results in separate companion papers, I'm sure that many of us would be happy to collaborate on these. best, Tuuli Tuuli Lappalainen, PhD Department of Genetics, Stanford University School of Medicine , and Department of Genetic Medicine and Development, University of Geneva Email:tuuli.e.lappalainen@gmail.com /tlappala(a)stanford.edu Tel: +1 415 351 9713 Bustamante lab Department of Genetics 300 Pasteur Dr. Lane L301 Stanford, CA 94305-5120 USA On /13/213 8:33 AM, Tuuli Lappalainen wrote: -- Tuuli Lappalainen, PhD Department of Genetics, Stanford University School of Medicine , and Department of Genetic Medicine and Development, University of Geneva Email:tuuli.e.lappalainen@gmail.com /tlappala(a)stanford.edu Tel: +1 415 351 9713 Bustamante lab Department of Genetics 300 Pasteur Dr. Lane L301 Stanford, CA 94305-5120 USA _______________________________________________ Geuvadis_rna_analysis mailing list Geuvadis_rna_analysis(a)lists.crg.es http://davinci.crg.es/mailman/listinfo/geuvadis_rna_analysis